English
Polski
Español
українська
Bleeding risk evaluation before anticoagulant therapy
How to properly evaluate bleeding risk before starting anticoagulation?
2020-10-02
How to properly evaluate bleeding risk before starting anticoagulation?
Should we switch patients treated with warfarin to direct oral anticoagulants (DOACs)? Who would benefit, and who would not?
What should be the treatment of cancer-associated thrombosis?
Is it rational to perform screening tests for malignancy in patients with unprovoked VTE?
A 23-year-old woman with an ovarian cyst treated with oral contraceptives develops lower limb edema. A diagnosis of deep vein thrombosis (DVT) is established solely on the basis of the D-dimer level. The patient receives LMWH and is sent home. After a few hours she develops pulmonary embolism (PE).
How long should anticoagulant treatment be used as venous thromboembolism (VTE) prophylaxis in hospitalized patients? Should it be continued after discharge?
What is the current role of mechanical venous thromboembolism (VTE) prophylaxis?
Who should receive venous thromboembolism (VTE) prophylaxis before a long-haul flight? What form of prophylaxis should be used?
What should be the diagnostic workup in a patient with suspected deep vein thrombosis (DVT)?
